arrow
F

Florence van Hunsel

Netherlands Pharmacovigilance Centre Lareb
H指数:27
被引数:3,176

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The WHO-ISoP Pharmacovigilance Curriculum: 2026 Update

WHO-ISoP 药物警戒课程:2026 年更新

2026-09-200
OAAI
Characteristics and temporal trends of EU teratological safety signals and information dissemination to healthcare professionals in the Netherlands—A contribution of the ConcePTION project

欧盟致畸性安全信号的特征及时序趋势以及向荷兰医疗保健专业人员的信息传播情况——ConcePTION项目的贡献

2026-05-280
OAAI
Adverse drug reactions following SARS-CoV-2 vaccination of 3805 healthcare workers cause substantial sick-leave and are correlated to vaccine regimen, age, sex and serological response

SARS-CoV-2疫苗接种后3805名医疗保健工作者出现的不良药物反应导致大量病假,并与疫苗接种方案、年龄、性别和血清学反应相关。

Vaccine
IF3.5
2025-08-060
OA
Safety of COVID-19 Vaccines among People with History of Allergy: A European Active Surveillance Study

过敏史人群中新型冠状病毒肺炎疫苗的安全性: 一项欧洲主动监测研究

2024-09-170
OAAI
What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European Covid Vaccine Monitor Active Surveillance Study
2024-06-222
OAAI
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement
2024-05-0735
OAAI
The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration
2024-05-0772
OAAI